SynchroPET Company
We build the smallest Positron Emission Tomography (PET) Scanners in medical imaging and research. Our first device promises to disrupt the nuclear imaging market by providing a non invasive input function that makes all PET scanners more quantitative and better at diagnosis and treatment of diseases like cancer, alzheimers, and parkinson's. This new quantitative data opens up and accelerates new possibilities in personalized medical treatments and cures.
Founded Date:
2013-03-01
Total Funding:
$9.5M
Investor Type:
For Profit
Employee Number:
1-10
Funding Status:
Early Stage Venture
Technology:
P4 Medicine
Last Funding Type:
Venture - Series Unknown
Investors Number:
5
Industry:
Biotechnology, Health Care, Health Diagnostics, Medical Device
Headquarters:
Stony Brook, New York, United States